| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0449 | Ac-5sglcnac | Novel, cell-permeable, potent O-GlcNAc transferase (OGT) inhibitor |
|
| DCC0450 | Ac-ats010-ke | Novel Selective, irreversible, and Rapid Cell-Permeable Inhibitor of Human Caspase-3 |
|
| DCC0451 | Acc1 Inhibitor 1q | Novel highly potent and selective acetyl-CoA carboxylase 1 (ACC1) inhibitor (hACC1: IC 50 =0.58nM, hACC2: IC 50 >10000nM) |
|
| DCC0452 | Acc2-in-2e | Novel Acetyl-CoA Carboxylase 2 (ACC2) Selective Inhibitor, Improving Whole-Body Insulin Resistance and Hyperglycemia in Diabetic Mice through Target-Dependent Pathways |
|
| DCC0453 | Acdala | Highly photodurable and blue-laser excitable fluorescent amino acid. acting as a highly fluorescent probe after being incorporated into specific positions of various antibodies, receptors, and enzymes |
|
| DCC0454 | Ac-devd-cho | Selective Caspase-3 inhibitor |
|
| DCC0455 | Acetaminosalol | Analgesic, antipyretic, and anti-inflammatory agent |
|
| DCC0456 | Acetobixan | Novel Inhibitor of Cellulose Synthesis |
|
| DCC0457 | Acetophenazine Dimaleate | Antipsychotic, targeting the dopamine D2 receptor |
|
| DCC0458 | Achn975 | Novel potent and selective LpxC inhibitor |
|
| DCC0459 | Acp-1n | Novel Inhibitor of BRD4-Driven Nucleoporin NUP210 Expression, Attenuating Colorectal Cancer Growth |
|
| DCC0460 | Activator-3 | Novel potent activator of pan-AMPK, enhancing AMPK phosphorylation by upstream kinase LKB1 and protecting AMPK complex against dephosphorylation by PP2C |
|
| DCC0461 | Acy-1083 | Novel selective HDAC6 inhibitor, showing 260-fold selectivity towards HDAC6 vs other HDACs |
|
| DCC0462 | Ad-10942-8 | Novel selective USP8 inhibitor (USP8 IC50 2.1 μM; USP7 >50μM) |
|
| DCC0463 | Ad-227 | Novel potent inhibitor of the MDM2-p53 interaction |
|
| DCC0464 | Adamantylamphetamine Hydrochloride | Potential antidepressant and anti-Parkinson agent |
|
| DCC0465 | Adamantylmethamphetamine Hcl | Potential antidepressant and anti-Parkinson agent |
|
| DCC0466 | Adamts-5 Inhibitor Featured | Selective inhibitor of ADAMTS-5 (A disintegrin and metalloproteinase with thrombospondin motifs 5 or aggrecanase-2) |
|
| DCC0467 | Adasgc | Novel Hsp40-Hsp70 chaperone complex inhibitor, inhibiting the Hsp40-stimulated ATPase activity of the Hsp70 chaperone, with a K i of ~10 μM |
|
| DCC0468 | Adep-2b | Novel inhibitor of ClpXP complexes, causing extremely rapid dissociation of ClpXP complexes, preventing ClpX rebinding following spontaneous dissociation |
|
| DCC0469 | Aderbasib | Novel sheddase inhibitor, inhibiting the ADAM (A Disintegrin And Metalloprotease) family of multifunctional membrane-bound proteins with potential antineoplastic activity |
|
| DCC0470 | Adinazolam Mesylate | Antidepressant and anxiolytic agent, binding to peripheral-type benzodiazepine receptors that interact allosterically with GABA receptors as an agonist to produce inhibitory effects |
|
| DCC0471 | Ad-isec | Novel Potent Mutant p53 Rescuing Agent |
|
| DCC0472 | Adjuvant | Novel antibiotic adjuvant, exhibiting as high as 4096-fold potentiation of multiple classes of antibiotics toward critical Gram-negative superbugs |
|
| DCC0473 | Adjuvant Nada | Novel antibiotic adjuvant, exhibiting as high as 4096-fold potentiation of multiple classes of antibiotics toward critical Gram-negative superbugs |
|
| DCC0474 | Adp-2341 | Novel soluble analog of FiVe1 |
|
| DCC0475 | Adp-hpd | Poly(ADP-Ribose) Glycohydrolase (PARG) inhibitor |
|
| DCC0476 | Adr-925 | Active iron-chelating metabolite of dexrazoxane |
|
| DCC0477 | Adrenaline Sulfate | Nonselective agonist of all adrenergic receptors, including the major subtypes alpha1, alpha2, ß1, ß2, and ß3 |
|
| DCC0478 | Ads-103317 | Novel Inhibitor of EGF-EGFR Interactions |
|
